✦ LIBER ✦
Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial
✍ Scribed by Strober, B.E.; Sobell, J.M.; Duffin, K.C.; Bao, Y.; Guérin, A.; Yang, H.; Goldblum, O.; Okun, M.M.; Mulani, P.M.
- Book ID
- 119826891
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 131 KB
- Volume
- 167
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.